Fact File: European COVID-19 Focus Shifts To Managing The ‘New Normal’
The evolution of how and where patients receive their care has received an unexpected boost from the COVID-19 crisis. Coronavirus volume testing challenges persist, but the global medtech industry is now looking beyond the crisis toward a return to “normal” business.
You may also be interested in...
South Korea, one of the first countries to be hit by the spread of COVID-19 from China, has implemented new standalone IVD regulations.
In an interview with Medtech Insight, two Ernst & Young health care leaders outline five trends for medtech companies to redefine their business models in response to COVID-19.
Having rapidly built a large-capacity COVID-19 testing strategy, Germany’s health system leaders are developing the capabilities to avert future outbreaks.